johnson & johnson news - Search News

Intra, Johnson & Johnson and Cellular

EconoTimes · 4h

Johnson & Johnson Eyes $10 Billion Biopharma Deal with Intra-Cellular Therapies

Johnson Johnson is reportedly exploring the acquisition of biopharmaceutical company Intra-Cellular Therapies, according to Bloomberg News. The potential deal, valued at approximately $10 billion, could be finalized

Business Insider · 7h

Johnson & Johnson In Talks To Acquire Intra-Cellular Therapies : Report

Johnson & Johnson (JNJ) is in talks to acquire Intra-Cellular Therapies Inc. (ITCI), a biopharmaceutical company focused on

Hosted on MSN · 11h

Johnson & Johnson Is Exploring Bid for Intra-Cellular Therapies

Johnson & Johnson is in talks to acquire Intra-Cellular Therapies Inc., a biopharmaceutical company focused on treatments for central nervous system disorders, people familiar with the matter said.

Reuters on MSN · 11h

J&J explores bid for Intra-Cellular Therapies, Bloomberg News reports

(Reuters) -Drug maker Johnson & Johnson is exploring a bid to acquire Intra-Cellular Therapies, a biopharmaceutical company, Bloomberg News reported on Sunday, citing people familiar with the matter.

Seeking Alpha on MSN · 11h

Johnson & Johnson exploring takeover of Intra-Cellular - Bloomberg

Johnson & Johnson (JNJ) is evaluating an offer to purchase Intra-Cellular Therapies (NASDAQ:ITCI). Deliberations are on going, and it's not a certainty that JNJ will make an offer for the biotech firm focused on treatments for mental health disorders,

1d

Johnson & Johnson Could Serve As High-Yield Bond Alternative

Johnson & Johnson remains a Buy for its stability and consistent dividends, despite short-term price fluctuations and modest ...

2d

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Johnson & Johnson (JNJ) And Encourages Investors to Reach Out

NEW YORK, NY / ACCESSWIRE / January 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf ...

2don MSN

Johnson & Johnson stock outperforms competitors despite losses on the day

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Johnson & Johnson MedTech halts Varipulse PFA cases due to stroke reports

Johnson & Johnson MedTech has temporarily paused all U.S. external evaluations and cases using its Varipulse pulse field ...

3d

Cautious Outlook on Johnson & Johnson Amid Currency and Legal Challenges

Wells Fargo analyst Larry Biegelsen maintained a Hold rating on Johnson & Johnson (JNJ – Research Report) yesterday and set a price target ...

4d

Dividend Roundup: Why I Prefer Johnson & Johnson Over Pfizer

Johnson & Johnson offers safer payouts and stronger growth. Discover why JNJ stock is the better dividend option compared to ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results